Double-Blind Study of Phenethyldiguanide in Weight Control of Obese Nondiabetic Subjects
Open Access
- 1 October 1966
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 19 (4) , 223-226
- https://doi.org/10.1093/ajcn/19.4.223
Abstract
A double-blind study of the effectiveness of phenformin, a phenethyldiguanide, in a weight reduction program of obese subjects with normal glucose tolerance was made. After fifteen weeks of drug administration the increased loss of weight in the group given phenformin could be attributed to the great weight losses in subjects genetically predisposed to diabetes. No change in fasting blood sugar or serum cholesterol levels was observed. Side effects were negligible. The exact mode of action of the diguanides remains unknown.Keywords
This publication has 10 references indexed in Scilit:
- Insulin-like activity in urine of normal and obese subjectsMetabolism, 1965
- Longevity and Mortality of DiabeticsAmerican Journal of Public Health and the Nations Health, 1965
- SERUM-INSULIN RESPONSE TO GLUCOSE IN PREDIABETIC SUBJECTSThe Lancet, 1965
- The present state of knowledge on the mode of action of the antidiabetic diguanidesMetabolism, 1964
- PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICSThe Lancet, 1964
- Metabolic Changes Associated With Obesity Before and After Weight ReductionJAMA, 1964
- Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical AssayDiabetes, 1963
- FOREARM METABOLISM IN OBESITY AND ITS RESPONSE TO INTRA-ARTERIAL INSULIN. CHARACTERIZATION OF INSULIN RESISTANCE AND EVIDENCE FOR ADAPTIVE HYPERINSULINISM*Journal of Clinical Investigation, 1962
- Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay TechnicDiabetes, 1960
- Carbohydrate Metabolism in “ACTIVE” AND “STATIC” HUMAN OBESITYThe American Journal of Clinical Nutrition, 1953